Immunogenicity of SARS-CoV-2 messenger RNA vaccines in patients with cancer
Alfredo Addeo, Pankil Shah, Natacha Bordry, Robert D. Hudson, Brenna Albracht, Mariagrazia Di Marco, Virginia Kaklamani, Pierre-Yves Dietrich, Barbara S. Taylor, Pierre-Francois Simand, Darpan I. Patel, Jing Wang, Sana Intidhar Labidi‐Galy, Sara Fertani, Robin J. Leach, José Luís Sandoval, Ruben A. Mesa, Kate Lathrop, Nicolas Mach, Dimpy P. Shah
Topics & Concepts
ImmunogenicityCancerVirologyMessenger RNASevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)RNACoronavirus disease 2019 (COVID-19)BiologyCancer vaccine2019-20 coronavirus outbreakComputational biologyMedicineImmunologyImmunotherapyImmune systemGeneGeneticsInfectious disease (medical specialty)OutbreakDiseasePathologySARS-CoV-2 and COVID-19 ResearchCOVID-19 and healthcare impactsCOVID-19 Clinical Research Studies